At 7.2% CAGR, Middle East & Africa Transfection Reagents and Equipment Market is Projected to be Worth US$ 80.53 Million by 2030, says Business Market Insights

According to Business Market Insights' research, the Middle East & Africa transfection reagents and equipment market was valued at US$ 46.15 million in 2022 and is expected to reach US$ 80.53 million by 2030, registering a CAGR of 7.2% from 2022 to 2030. Strategic initiatives by companies and ramping up small-scale processes to large-scale processes are among the critical factors attributed to the Middle East & Africa transfection reagents and equipment market expansion.

Companies operating in the Middle East & Africa transfection reagents and equipment market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic scope, and enhance their capacities to cater to a larger than existing customer base. These developments also contribute to the introduction of new trends to the market to a certain extent. A few of the noteworthy developments in the Middle East & Africa transfection reagents and equipment market are mentioned below.

• In April 2023, Thermo Fisher Scientific launched the Invitrogen Neon NxT Electroporation System that facilitates transfection, even with the most challenging cell types, enabling high efficiency, cell recovery, and reproducibility. Neon NxT electrodes are optimally placed to provide minimal surface area and create a more uniform electric field, and maintain apt physiological conditions during transfection, thereby enabling the desired modification to take place in more cells and reducing the number of cells lost during the process. The new system also features an improved feedback loop and ergonomic enhancements for ease of use.
  
  Thus, the introduction of products such as transfection reagents and systems; the development of innovative products targeting various health issues to create new or improved products; and the initiation of new businesses to remain competitive in the market, all, through collaborations and partnerships can help speed up the development of new platforms for transfection reagents and equipment.
  
  On the contrary, high cost of instruments and consumables hampers the growth of Middle East & Africa transfection reagents and equipment market.
  
  Based on product, the Middle East & Africa transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held 77.0% share of the Middle East & Africa transfection reagents and equipment market in 2022, amassing US$ 35.55 million. It is projected to garner US$ 62.56 million by 2030 to expand at 7.3% CAGR during 2022-2030.
  
  In terms of method, the Middle East & Africa transfection reagents and equipment market is segmented into viral methods, non viral methods, and hybrid methods. The non-viral methods segment held 56.2% share of the Middle East & Africa transfection reagents and equipment market in 2022, amassing US$ 25.93 million. It is estimated to garner US$ 45.79 million by 2030 to expand at 7.4% CAGR during 2022-2030. The viral segment is subcategorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.
  
  By application, the Middle East & Africa transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held 52.6% share of Middle East & Africa transfection reagents and equipment market in 2022, amassing US$ 24.26 million. It is predicted to garner US$ 42.92 million by 2030 to expand at 7.4% CAGR during 2022-2030.
  
  Based on end user, the Middle East & Africa transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held 65.8% share of the Middle East & Africa transfection reagents and equipment market in 2022, amassing US$ 30.38 million. It is projected to garner US$ 52.69 million by 2030 to expand at 7.1% CAGR during 2022-2030.
  
  Based on country, the Middle East & Africa transfection reagents and equipment market is categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held 46.9% share of Middle East & Africa transfection reagents and equipment market in 2022, amassing US$ 21.63 million. It is projected to garner US$ 38.64 million by 2030 to expand at 7.5% CAGR during 2022-2030.
  
  Key players operating in the Middle East & Africa transfection reagents and equipment market are Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, and MaxCyte Inc, among others.
  
  

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com